A Phase 2, Open Label Study of the Safety, Antiretroviral Activity and Pharmacokinetics of 3BNC117 During a Short Analytical Treatment Interruption in HIV-infected Subjects
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Teropavimab (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2018 New trial record